Acute Myelomonocytic Leukemia - Symptoms, Reasons and Treatment
Written by Medicover Team and Medically Reviewed by Dr Nilesh Wasekar , Hematologists
Table of Contents
Acute Myelomonocytic Leukemia (AMML), also known as AML-M4 in the French-American-British (FAB) classification, is a subtype of acute myeloid leukemia (AML). It is characterized by the rapid growth of abnormal myeloid and monocytic cells in the bone marrow, which interfere with the production of healthy blood cells. Without prompt treatment, the disease can progress quickly, but advances in chemotherapy, targeted therapy, and stem cell transplantation have improved outcomes for many patients.
What Are the Types of Acute Myelomonocytic Leukemia?
Acute Myelomonocytic Leukemia is primarily classified into the following subtypes:
- Acute Myelomonocytic Leukemia (AML-M4): Involves both granulocytic and monocytic leukemia cells.
- Acute Myelomonocytic Leukemia with Eosinophilia (AML-M4Eo): A subtype associated with increased abnormal eosinophils and often linked to inv(16) or t(16;16) chromosomal abnormalities. This subtype generally has a more favorable prognosis with appropriate treatment.
What Are the Symptoms of Acute Myelomonocytic Leukemia?
Symptoms develop rapidly due to the replacement of normal bone marrow cells by leukemia cells.
- Persistent fatigue and weakness
- Frequent infections or fever
- Easy bruising or prolonged bleeding
- Pale skin due to anemia
- Shortness of breath
- Swollen gums (gingival enlargement)
- Bone or joint pain
- Enlarged lymph nodes, liver, or spleen
- Unexplained weight loss and loss of appetite
What Are the Causes of Acute Myelomonocytic Leukemia?
The exact cause is often unknown, but several factors increase the risk of developing Acute Myelomonocytic Leukemia.
- Genetic mutations in bone marrow cells
- Chromosomal abnormalities such as inv(16) or t(16;16)
- Previous chemotherapy or radiation therapy
- Exposure to benzene or other industrial chemicals
- Smoking
- Certain inherited genetic disorders
- Previous blood disorders such as myelodysplastic syndrome
When to See a Doctor?
Consult a haematologist if you experience persistent
- Fatigue
- Unexplained bruising or
- Bleeding
- Recurrent infections
- Prolonged fever
- Swollen gums
- Bone pain
- Unexplained weight loss
These symptoms may indicate Acute Myelomonocytic Leukemia or another blood disorder and require prompt evaluation. Early diagnosis and treatment by a hematologist can improve treatment outcomes and reduce the risk of complications.
Find Hematologists for Acute Myelomonocytic Leukemia Treatment Near You
How is Acute Myelomonocytic Leukemia Diagnosed?
Diagnosis involves laboratory tests and specialized examinations to confirm the disease and determine its subtype.
- Physical examination: Evaluation for enlarged lymph nodes, liver, spleen, or gum enlargement.
- Complete blood count (CBC): Detects abnormal white blood cells, anemia, and low platelet counts.
- Peripheral blood smear: Identifies leukemia blast cells.
- Bone marrow aspiration and biopsy: Confirms the diagnosis and evaluates the percentage of blast cells.
- Flow cytometry (immunophenotyping): Determines the specific leukemia cell type.
- Cytogenetic testing: Detects chromosomal abnormalities such as inv(16) or t(16;16).
- Molecular genetic testing: Identifies gene mutations that guide treatment decisions.
How is Acute Myelomonocytic Leukemia Treated?
Treatment aims to achieve remission, eliminate leukemia cells, and prevent relapse.
- Induction chemotherapy: Intensive chemotherapy to destroy leukemia cells and achieve remission.
- Consolidation chemotherapy: Additional treatment to eliminate any remaining leukemia cells.
- Targeted therapy: Used for patients with specific genetic mutations when appropriate.
- Stem cell (bone marrow) transplantation: Recommended for selected high-risk patients or those with recurrent disease.
- Supportive care: Blood transfusions, antibiotics, antifungal medications, and growth factors help manage treatment-related complications.
- Clinical trials: May provide access to newer therapies for eligible patients.
Your health is everything - prioritize your well-being today.
What Are the Precautions for Acute Myelomonocytic Leukemia Complications?
Following medical advice and preventive measures can help reduce complications during treatment and recovery.
- Attend all scheduled oncology follow-up appointments.
- Take medications exactly as prescribed.
- Practice good hand hygiene and avoid contact with sick individuals.
- Seek immediate medical care for fever or signs of infection.
- Avoid activities that increase the risk of bleeding or injury.
- Eat a balanced, nutritious diet and stay well hydrated.
- Report unusual bruising, bleeding, severe fatigue, or new symptoms promptly.
- Follow your healthcare team's recommendations regarding vaccinations and infection prevention.
Frequently Asked Questions
1. What early signs should I look for with Acute Myelomonocytic Leukemia?
Look for fatigue, pale skin, fever, easy bruising, and bone pain. Prompt medical evaluation is crucial for diagnosis and treatment.
2. What lifestyle changes should I make to manage Acute Myelomonocytic Leukemia effectively?
Follow a balanced diet, stay active, get enough rest, avoid smoking and limit alcohol intake. Regularly monitor your blood counts and attend follow-up appointments to manage overall health effectively.
3. How can Acute Myelomonocytic Leukemia affect the body in the long term?
AML can lead to complications like infections, anemia, and bleeding. Long-term effects may include organ damage and increased risk of relapse.
4. How is Acute Myelomonocytic Leukemia typically managed?
Treatment for Acute Myelomonocytic Leukemia often involves chemotherapy, stem cell transplant, and supportive care to manage symptoms.
5. Can Acute Myelomonocytic Leukemia return even after successful treatment?
Yes, Acute Myelomonocytic Leukemia can return after successful treatment. Regular follow-up is important to monitor for recurrence.